Zymeworks (ZYME) Asset Utilization Ratio (2022 - 2026)
Zymeworks (ZYME) reported Asset Utilization Ratio of 0.2 for Q1 2026, down 6.24% on a YoY basis from 0.21 in Q1 2025, and down 30.84% sequentially from 0.28 in Q4 2025.
Zymeworks (ZYME) Asset Utilization Ratio (2022 - 2026) Analysis & Trends
Zymeworks (ZYME) has 5 years of Asset Utilization Ratio data on file, last reported at 0.2 in Q1 2026.
- For the quarter ending Q1 2026, Asset Utilization Ratio fell 6.24% year-over-year to 0.2; the trailing twelve-month figure through Mar 2026 stood at 0.2 (down 6.24% YoY), and the FY2025 full-year result was 0.26, up 79.07% from the prior year.
- Asset Utilization Ratio slipped to 0.2 in Q1 2026, from 0.28 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.71 in Q4 2022 to a low of 0.09 in Q1 2024.
- A 5-year average of 0.32 and a median of 0.25 in 2025 frame the typical range for Asset Utilization Ratio.
- Across the five-year window, Asset Utilization Ratio tumbled 84.93% in 2024 and surged 169.11% in 2025, its largest moves.
- Tracing ZYME's Asset Utilization Ratio over 5 years: stood at 0.71 in 2022, then sank by 81.07% to 0.13 in 2023, then rose by 20.14% to 0.16 in 2024, then surged by 77.42% to 0.28 in 2025, then tumbled by 30.84% to 0.2 in 2026.
- Business Quant data shows ZYME's Asset Utilization Ratio at 0.2 in Q1 2026, 0.28 in Q4 2025, and 0.33 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.69 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Zymeworks | 1.70 Bn | 1.34 Bn | - | 0.20 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.20 |
| Dec 31, 2025 | 0.28 |
| Sep 30, 2025 | 0.33 |
| Jun 30, 2025 | 0.29 |
| Mar 31, 2025 | 0.21 |
| Dec 31, 2024 | 0.16 |
| Sep 30, 2024 | 0.12 |
| Jun 30, 2024 | 0.12 |
| Mar 31, 2024 | 0.09 |
| Dec 31, 2023 | 0.13 |
| Sep 30, 2023 | 0.66 |
| Jun 30, 2023 | 0.62 |
| Mar 31, 2023 | 0.59 |
| Dec 31, 2022 | 0.71 |